In the next step, we aim to exploit the depletion of PDE7A using clustered regularly interspaced short palindromic repeats (CRISPR)-knock-out technology in NSCs and apply the engineered NSCs-CRISPR-PDE7A to mice exposed to sevoflurane or mice with PD or AD symptoms. This evidence concerns the gene PDE7A and Alzheimer disease.